Healthcare, Regulatory and Reimbursement Landscape in US: JSBMarketResearch

JSB Market Research
announced latest market research report Titled “CountryFocus: Healthcare,
Regulatory and Reimbursement Landscape - US". The report is an essential
source of information on and analysis of the healthcare, regulatory and
reimbursement landscape in the US.
Summary
CountryFocus:
Healthcare, Regulatory and Reimbursement Landscape - US. The report is an
essential source of information on and analysis of the healthcare, regulatory
and reimbursement landscape in the US. It identifies key trends in the
country’s healthcare market and provides insights into its demographic,
regulatory, and reimbursement landscape and healthcare infrastructure. Most
importantly, the report provides valuable insights into the trends and
segmentation of its pharmaceutical and medical devices markets. It uses data
and information sourced from proprietary databases, secondary research, and
in-house analysis by GlobalData’s team of industry experts.
The population of the US in 2013 amounted to 316.1 million,
having grown at a Compound Annual Growth Rate (CAGR) of 0.8% from 2008. The
country’s increasingly elderly population and corresponding increase in the
incidence of chronic diseases will help to boost the growth of the
pharmaceutical market, which was worth $326.9 billion in 2008, a value that is
expected to have reached $548.4 billion by 2020 at a CAGR of 4.4%.
Approximately 86.6% of the US population has healthcare coverage, which has
helped to create an efficient healthcare system. New initiatives taken by the
Food and Drug Administration (FDA) have strengthened the review and approval
process. The value of the US medical device market was $116.2 billion in 2008,
and is expected to register a CAGR of 5.0% to reach an estimated $209.7 billion
in 2020.
These growth trends can be primarily attributed to -
- Sedentary lifestyles, leading to a high chronic disease
burden
- High public healthcare expenditure by the Centers for
Medicare and Medicaid Services (CMS)
- Increased R&D expenditure
- Easily accessible diagnostic technologies
Scope
The report provides information on the healthcare,
regulatory, and reimbursement landscape in the US, and includes -
- An overview of the pharmaceutical and medical device
markets, including market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the
pharmaceuticals market: Pfizer, Merck, Novartis, Sanofi and Abbott; and
profiles and SWOT analyses of the major players in the medical device market:
Medtronic, DePuy, Siemens Healthcare, Abbott Laboratories, and Stryker
- Insightful review of the reimbursement and regulatory
landscape, with analysis covering details of the country’s healthcare
reimbursement process, regulatory agencies and the approval processes for new
drugs and medical devices
- Detailed analysis of the political and economic
environment, covering economic indicators, demographics, healthcare
infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to
growth in the healthcare market
View Full Report with TOC @ http://www.jsbmarketresearch.com/healthcare-medical/r-countryfocus-healthcare-regulatory-and-reimbursement-landscape-us-167622
Reasons to buy
This report
will enhance your decision-making capability by allowing you to -
- Develop
business strategies by understanding the trends shaping and driving the US
healthcare market
- Drive
revenue by understanding the key trends, reimbursement and regulatory policies,
pharmaceutical market segments, and companies likely to affect the US
healthcare market in the future
- Formulate
effective sales and marketing strategies by understanding the competitive
landscape and analyzing the performance of various competitors
- Organize
your sales and marketing efforts by identifying the market categories and
segments that present the best opportunities for consolidation, investment, and
strategic partnerships
- Identify,
understand, and capitalize on the opportunities and challenges in the US
healthcare market
Table of Contents
1.1 List
of Tables 11
1.2 List
of Figures 15
2 Introduction 19
2.1
GlobalData Report Guidance 19
3 Overview of Pharmaceutical and
Medical Device Markets 20
3.1
Pharmaceutical Market 20
3.1.1
Market Overview 20
3.1.2 Pharmaceutical
Exports and Imports 25
3.1.3
Supply Channels 27
3.1.4
Market Segments 28
3.1.5
Overview of Top Five Disease Areas 32
3.1.6
Major Players 35
3.2
Medical Device Market 75
3.2.1
Market Overview 75
3.2.2
Overview of the Top Five Segments 77
3.2.3
Diagnostic Market 90
Comments